[PDF][PDF] Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl) 4-iodobenzamide SPECT

H Everaert, A Bossuyt, P Flamen… - Journal of Nuclear …, 1997 - Soc Nuclear Med
… We evaluated the potential clinical applica bility of 123l-N-(2-diethylaminoethyl) 4-iodobenzamide
<[123I]IDAB) for SPECT imaging of ocular melanoma. Methods: Fourteen pa tients were …

[PDF][PDF] Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM)

L Maffioli, L Mascheroni, V Mongioj… - Journal of Nuclear …, 1994 - Soc Nuclear Med
… pathologic uptake was documented in the SPECT stud ies of the brain. … The spleen was not
visualized in seven cases. In the … N-(2-diethylaminoethyl)-4[123I]iodobenzamide as a tracer …

[PDF][PDF] Pharmacokinetics of iodine-123-IMBA for melanoma imaging

C Nicholl, A Mohammed, WE Hull… - Journal of Nuclear …, 1997 - Soc Nuclear Med
… with several N-(2-dialkylaminoalkyl)-4-iodobenzamide … -free solution of N-(2-diethylaminoethyl)-4-methoxybenzamide
(10 … Nontarget tissue clear ance of radioactivity was visualized by …

123I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial

F Cachin, E Miot-Noirault, B Gillet… - Journal of Nuclear …, 2014 - Soc Nuclear Med
… history of cutaneous or ocular melanoma were included from … technique that can reliably
visualize malignancy in structures … compound, N-(2-diethylaminoethyl)-4-iodobenzamide (BZA), …

[HTML][HTML] Theranostic approach for metastatic pigmented melanoma using ICF15002, a multimodal radiotracer for both PET imaging and targeted radionuclide therapy

L Rbah-Vidal, A Vidal, EMF Billaud, S Besse… - Neoplasia, 2017 - Elsevier
… on the human eyes except in the case of ocular melanoma, whereas great uveal uptake
was … melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide) …

[PDF][PDF] Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma

W Brandau, T Niehoff, P Pulawski… - Journal of Nuclear …, 1996 - Soc Nuclear Med
… compounds, N-(2-diethylaminoethyl)-4-['23I]iodobenzamide … SPECT studies were performed
at 5 hr pi using a three-… of malignant melanoma and mÃĐtastaseswith iodine- 123-N-…

In Vivo and In Vitro Detection of Dopamine D2 Receptors in Uveal Melanomas

L Bodei, LJ Hofland, D Ferone, CM Mooy… - Cancer Biotherapy …, 2003 - liebertpub.com
… , in both planar and single photon emission tomography (SPECT) … uveal melanomas
revealed variable glucose consumption among ocular lesions,9,10 thus enabling the visualization

… -iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging

W Brenner, HJ Klomp, KH Bohuslavizki… - European journal of …, 1999 - Springer
… to stop the current study, especially with respect to the results of 201Tl in the same patient
melanoma and metastases with iodine-123-N-(2-diethylaminoethyl-4-iodobenzamide). J …

PET and SPECT imaging of melanoma: the state of the art

W Wei, EB Ehlerding, X Lan, Q Luo, W Cai - European journal of nuclear …, 2018 - Springer
… Interestingly, recent research has proposed that N-(2-diethylaminoethyl) rather than the
aromatic … Ga-TRAP(RGD) 3 showed high-contrast visualization of the M21 tumor. e Chemical …

Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation

S Mansard, J Papon, MF Moreau… - Nuclear medicine and …, 2005 - Elsevier
ocular melanoma as opposed to nonmalignant (ocular naevi) or nonmelanocytic tumors [6].
N-(2-diethylaminoethyl)-4-iodobenzamide (… invalidates potential use for the SPECT imaging …